BRIEF published on 02/21/2025 at 14:13, 1 year 8 months ago Artnet Unveils AI-powered Chatbot for Art Market Insights Data Analytics Artnet AI-powered Chatbot Auction Data Art Market Insights
BRIEF published on 02/21/2025 at 14:13, 1 year 8 months ago Artnet dévoile un chatbot basé sur l'IA pour obtenir des informations sur le marché de l'art Analyse Des Données Artnet Chatbot Alimenté Par L'IA Informations Sur Le Marché De L'art Données D'enchères
BRIEF published on 02/21/2025 at 14:05, 1 year 8 months ago Data Modernization Crucial for AI's Future, Amdocs Study Reveals Data Governance Cloud Architecture AI Investment Agentic AI Data Modernization
BRIEF published on 02/21/2025 at 14:05, 1 year 8 months ago La modernisation des données est cruciale pour l'avenir de l'IA, révèle une étude d'Amdocs Gouvernance Des Données Investissement En IA IA Agentique Modernisation Des Données Architecture Du Cloud
BRIEF published on 02/21/2025 at 14:05, 1 year 8 months ago Telomir Pharmaceuticals Breaks New Ground with Silver Ion Stabilization Market Potential Antimicrobial Treatments Silver Ion Stabilization Medical Breakthrough Chronic Wound Management
BRIEF published on 02/21/2025 at 14:05, 1 year 8 months ago Telomir Pharmaceuticals innove avec la stabilisation des ions argent Potentiel Du Marché Stabilisation Des Ions D'argent Une Percée Médicale Traitements Antimicrobiens Gestion Des Plaies Chroniques
BRIEF published on 02/21/2025 at 13:35, 1 year 8 months ago Vision Marine Technologies Initiates Stock Repurchase Program Shareholder Value Electric Propulsion Vision Marine Stock Repurchase NASDAQ:VMAR
BRIEF published on 02/21/2025 at 13:35, 1 year 8 months ago Vision Marine Technologies lance un programme de rachat d'actions Rachat D'actions Valeur Actionnariale Vision Marine Propulsion Électrique NASDAQ:VMAR
BRIEF published on 02/21/2025 at 13:05, 1 year 8 months ago Protagonist Therapeutics Announces 2024 Financial Results and Corporate Progress Protagonist Therapeutics Financial Results 2024 Icotrokinra Milestone Rusfertide VERIFY Trial Takeda Collaboration
BRIEF published on 02/21/2025 at 13:05, 1 year 8 months ago Protagonist Therapeutics annonce ses résultats financiers et les progrès de l'entreprise pour 2024 Résultats Financiers 2024 Thérapeutique Protagoniste Étape Importante De L'Icotrokinra Essai Rusfertide VERIFY Collaboration Avec Takeda
Published on 11/06/2026 at 00:53, 2 hours 27 minutes ago Sekur Private Data Engages Darkstar Capital for Investor Awareness and Sekur Product Distribution
Published on 11/06/2026 at 00:45, 2 hours 35 minutes ago Gabriel Announces Closure of ICSID Annulment Proceedings
Published on 11/05/2026 at 23:55, 3 hours 25 minutes ago Santé Canada autorise deux vaccins à ARNm de Moderna : un vaccin contre la grippe et un vaccin combiné contre la grippe et la COVID-19
Published on 11/05/2026 at 23:20, 4 hours ago Health Canada Authorizes Moderna's mRNA Influenza and Combination Influenza and COVID-19 Vaccines
Published on 11/06/2026 at 00:05, 3 hours 15 minutes ago RBI: Announcement of the result of the voluntary public tender offer for all Addiko shares following expiration of the grace period
Published on 11/05/2026 at 22:05, 5 hours 14 minutes ago Quantinuum Reports Third Quarter 2026 Results and Raises Full-Year Revenue Outlook
Published on 11/05/2026 at 20:38, 6 hours 41 minutes ago freenet uses funds from Ceconomy sale for waipu.tv acquisition and share buyback
Published on 11/05/2026 at 20:37, 6 hours 43 minutes ago EQS-Adhoc: freenet AG decides on share buyback programme for up to EUR 75 million
Published on 11/05/2026 at 19:45, 7 hours 34 minutes ago Stabilus SE fulfills forecast for fiscal 2026 and adjusts 2030 medium-term targets
Published on 11/05/2026 at 18:21, 8 hours 58 minutes ago Capital et droits de vote au 31 octobre 2026
Published on 11/05/2026 at 18:21, 8 hours 58 minutes ago Total number of voting rights and shares making up the share capital at October 31, 2026
